ARCHIVES

In Brief: Calabresi Named To President’s Cancer Panel; Mays Leaves NCI Technology Office For IVAX

This article is from The Cancer Letter archive.

Vol. 21 No. 18 | May 5, 1995

Download PDF Visit The Full Archive

Related Articles

Senators Urge Grassroots Support For Health Research Fund Legislation

May 16, 1997

Improved Therapies For Cervical Cancer Said To Show Promise In Clinical Trials

March 26, 2004

Hydridoma Cell Lines Available

March 5, 1982

41 CCOPs Reported For Recompetition

February 23, 1990

RFAs For New Improve Accrual Of Minorities, Women

February 2, 1996

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

December 26, 2014